drugset / Trial / NCT05791565

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

NCT05791565

Phase 1 Completed 28 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study will be conducted to compare the PK of salbutamol administered via metered dose inhalers (MDI) containing propellants 1,1-difluroethane (HFA-152a) and 1,1,1,2-tetrafluoroethane (HFA-134a) in healthy participants.

Timeline

Start
2023-04-03
Primary completion
2023-05-21
Completion
2023-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown Inhaled

Indications